1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type: 2018 VS 2022 VS 2029 1.2.2 AI Platfrom 1.2.3 Analytics Service 1.3 Market by Application 1.3.1 Global Artificial Intelligence Drug R&D Market Growth by Application: 2018 VS 2022 VS 2029 1.3.2 Drug Discovery 1.3.3 Precision Medicine 1.4 Study Objectives 1.5 Years Considered 1.6 Years Considered 2 Global Growth Trends 2.1 Global Artificial Intelligence Drug R&D Market Perspective (2018-2029) 2.2 Artificial Intelligence Drug R&D Growth Trends by Region 2.2.1 Global Artificial Intelligence Drug R&D Market Size by Region: 2018 VS 2022 VS 2029 2.2.2 Artificial Intelligence Drug R&D Historic Market Size by Region (2018-2023) 2.2.3 Artificial Intelligence Drug R&D Forecasted Market Size by Region (2024-2029) 2.3 Artificial Intelligence Drug R&D Market Dynamics 2.3.1 Artificial Intelligence Drug R&D Industry Trends 2.3.2 Artificial Intelligence Drug R&D Market Drivers 2.3.3 Artificial Intelligence Drug R&D Market Challenges 2.3.4 Artificial Intelligence Drug R&D Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Artificial Intelligence Drug R&D Players by Revenue 3.1.1 Global Top Artificial Intelligence Drug R&D Players by Revenue (2018-2023) 3.1.2 Global Artificial Intelligence Drug R&D Revenue Market Share by Players (2018-2023) 3.2 Global Artificial Intelligence Drug R&D Market Share by Company Type (Tier 1, Tier 2, and Tier 3) 3.3 Players Covered: Ranking by Artificial Intelligence Drug R&D Revenue 3.4 Global Artificial Intelligence Drug R&D Market Concentration Ratio 3.4.1 Global Artificial Intelligence Drug R&D Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Artificial Intelligence Drug R&D Revenue in 2022 3.5 Artificial Intelligence Drug R&D Key Players Head office and Area Served 3.6 Key Players Artificial Intelligence Drug R&D Product Solution and Service 3.7 Date of Enter into Artificial Intelligence Drug R&D Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Artificial Intelligence Drug R&D Breakdown Data by Type 4.1 Global Artificial Intelligence Drug R&D Historic Market Size by Type (2018-2023) 4.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2024-2029) 5 Artificial Intelligence Drug R&D Breakdown Data by Application 5.1 Global Artificial Intelligence Drug R&D Historic Market Size by Application (2018-2023) 5.2 Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2024-2029) 6 North America 6.1 North America Artificial Intelligence Drug R&D Market Size (2018-2029) 6.2 North America Artificial Intelligence Drug R&D Market Growth Rate by Country: 2018 VS 2022 VS 2029 6.3 North America Artificial Intelligence Drug R&D Market Size by Country (2018-2023) 6.4 North America Artificial Intelligence Drug R&D Market Size by Country (2024-2029) 6.5 United States 6.6 Canada 7 Europe 7.1 Europe Artificial Intelligence Drug R&D Market Size (2018-2029) 7.2 Europe Artificial Intelligence Drug R&D Market Growth Rate by Country: 2018 VS 2022 VS 2029 7.3 Europe Artificial Intelligence Drug R&D Market Size by Country (2018-2023) 7.4 Europe Artificial Intelligence Drug R&D Market Size by Country (2024-2029) 7.5 Germany 7.6 France 7.7 U.K. 7.8 Italy 7.9 Russia 7.10 Nordic Countries 8 Asia-Pacific 8.1 Asia-Pacific Artificial Intelligence Drug R&D Market Size (2018-2029) 8.2 Asia-Pacific Artificial Intelligence Drug R&D Market Growth Rate by Region: 2018 VS 2022 VS 2029 8.3 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2018-2023) 8.4 Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2024-2029) 8.5 China 8.6 Japan 8.7 South Korea 8.8 Southeast Asia 8.9 India 8.10 Australia 9 Latin America 9.1 Latin America Artificial Intelligence Drug R&D Market Size (2018-2029) 9.2 Latin America Artificial Intelligence Drug R&D Market Growth Rate by Country: 2018 VS 2022 VS 2029 9.3 Latin America Artificial Intelligence Drug R&D Market Size by Country (2018-2023) 9.4 Latin America Artificial Intelligence Drug R&D Market Size by Country (2024-2029) 9.5 Mexico 9.6 Brazil 10 Middle East & Africa 10.1 Middle East & Africa Artificial Intelligence Drug R&D Market Size (2018-2029) 10.2 Middle East & Africa Artificial Intelligence Drug R&D Market Growth Rate by Country: 2018 VS 2022 VS 2029 10.3 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2018-2023) 10.4 Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2024-2029) 10.5 Turkey 10.6 Saudi Arabia 10.7 UAE 11 Key Players Profiles 11.1 IBM Watson 11.1.1 IBM Watson Company Detail 11.1.2 IBM Watson Business Overview 11.1.3 IBM Watson Artificial Intelligence Drug R&D Introduction 11.1.4 IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2018-2023) 11.1.5 IBM Watson Recent Development 11.2 BioXel 11.2.1 BioXel Company Detail 11.2.2 BioXel Business Overview 11.2.3 BioXel Artificial Intelligence Drug R&D Introduction 11.2.4 BioXel Revenue in Artificial Intelligence Drug R&D Business (2018-2023) 11.2.5 BioXel Recent Development 11.3 Insilico Medicine 11.3.1 Insilico Medicine Company Detail 11.3.2 Insilico Medicine Business Overview 11.3.3 Insilico Medicine Artificial Intelligence Drug R&D Introduction 11.3.4 Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2018-2023) 11.3.5 Insilico Medicine Recent Development 11.4 Gatehouse Bio 11.4.1 Gatehouse Bio Company Detail 11.4.2 Gatehouse Bio Business Overview 11.4.3 Gatehouse Bio Artificial Intelligence Drug R&D Introduction 11.4.4 Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2018-2023) 11.4.5 Gatehouse Bio Recent Development 11.5 Google DeepMind 11.5.1 Google DeepMind Company Detail 11.5.2 Google DeepMind Business Overview 11.5.3 Google DeepMind Artificial Intelligence Drug R&D Introduction 11.5.4 Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2018-2023) 11.5.5 Google DeepMind Recent Development 11.6 Genpact Cora 11.6.1 Genpact Cora Company Detail 11.6.2 Genpact Cora Business Overview 11.6.3 Genpact Cora Artificial Intelligence Drug R&D Introduction 11.6.4 Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2018-2023) 11.6.5 Genpact Cora Recent Development 11.7 Cyclica Inc 11.7.1 Cyclica Inc Company Detail 11.7.2 Cyclica Inc Business Overview 11.7.3 Cyclica Inc Artificial Intelligence Drug R&D Introduction 11.7.4 Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2018-2023) 11.7.5 Cyclica Inc Recent Development 11.8 QuantumBlack 11.8.1 QuantumBlack Company Detail 11.8.2 QuantumBlack Business Overview 11.8.3 QuantumBlack Artificial Intelligence Drug R&D Introduction 11.8.4 QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2018-2023) 11.8.5 QuantumBlack Recent Development 11.9 Nq Medical 11.9.1 Nq Medical Company Detail 11.9.2 Nq Medical Business Overview 11.9.3 Nq Medical Artificial Intelligence Drug R&D Introduction 11.9.4 Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2018-2023) 11.9.5 Nq Medical Recent Development 11.10 Phenomic AI 11.10.1 Phenomic AI Company Detail 11.10.2 Phenomic AI Business Overview 11.10.3 Phenomic AI Artificial Intelligence Drug R&D Introduction 11.10.4 Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2018-2023) 11.10.5 Phenomic AI Recent Development 11.11 Palantir Technologies 11.11.1 Palantir Technologies Company Detail 11.11.2 Palantir Technologies Business Overview 11.11.3 Palantir Technologies Artificial Intelligence Drug R&D Introduction 11.11.4 Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2018-2023) 11.11.5 Palantir Technologies Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Artificial Intelligence Drug R&D Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029 Table 2. Key Players of AI Platfrom Table 3. Key Players of Analytics Service Table 4. Global Artificial Intelligence Drug R&D Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029 Table 5. Global Artificial Intelligence Drug R&D Market Size by Region (US$ Million): 2018 VS 2022 VS 2029 Table 6. Global Artificial Intelligence Drug R&D Market Size by Region (2018-2023) & (US$ Million) Table 7. Global Artificial Intelligence Drug R&D Market Share by Region (2018-2023) Table 8. Global Artificial Intelligence Drug R&D Forecasted Market Size by Region (2024-2029) & (US$ Million) Table 9. Global Artificial Intelligence Drug R&D Market Share by Region (2024-2029) Table 10. Artificial Intelligence Drug R&D Market Trends Table 11. Artificial Intelligence Drug R&D Market Drivers Table 12. Artificial Intelligence Drug R&D Market Challenges Table 13. Artificial Intelligence Drug R&D Market Restraints Table 14. Global Artificial Intelligence Drug R&D Revenue by Players (2018-2023) & (US$ Million) Table 15. Global Artificial Intelligence Drug R&D Market Share by Players (2018-2023) Table 16. Global Top Artificial Intelligence Drug R&D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Drug R&D as of 2022) Table 17. Ranking of Global Top Artificial Intelligence Drug R&D Companies by Revenue (US$ Million) in 2022 Table 18. Global 5 Largest Players Market Share by Artificial Intelligence Drug R&D Revenue (CR5 and HHI) & (2018-2023) Table 19. Key Players Headquarters and Area Served Table 20. Key Players Artificial Intelligence Drug R&D Product Solution and Service Table 21. Date of Enter into Artificial Intelligence Drug R&D Market Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Artificial Intelligence Drug R&D Market Size by Type (2018-2023) & (US$ Million) Table 24. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2018-2023) Table 25. Global Artificial Intelligence Drug R&D Forecasted Market Size by Type (2024-2029) & (US$ Million) Table 26. Global Artificial Intelligence Drug R&D Revenue Market Share by Type (2024-2029) Table 27. Global Artificial Intelligence Drug R&D Market Size by Application (2018-2023) & (US$ Million) Table 28. Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2018-2023) Table 29. Global Artificial Intelligence Drug R&D Forecasted Market Size by Application (2024-2029) & (US$ Million) Table 30. Global Artificial Intelligence Drug R&D Revenue Market Share by Application (2024-2029) Table 31. North America Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 32. North America Artificial Intelligence Drug R&D Market Size by Country (2018-2023) & (US$ Million) Table 33. North America Artificial Intelligence Drug R&D Market Size by Country (2024-2029) & (US$ Million) Table 34. Europe Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 35. Europe Artificial Intelligence Drug R&D Market Size by Country (2018-2023) & (US$ Million) Table 36. Europe Artificial Intelligence Drug R&D Market Size by Country (2024-2029) & (US$ Million) Table 37. Asia-Pacific Artificial Intelligence Drug R&D Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029 Table 38. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2018-2023) & (US$ Million) Table 39. Asia-Pacific Artificial Intelligence Drug R&D Market Size by Region (2024-2029) & (US$ Million) Table 40. Latin America Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 41. Latin America Artificial Intelligence Drug R&D Market Size by Country (2018-2023) & (US$ Million) Table 42. Latin America Artificial Intelligence Drug R&D Market Size by Country (2024-2029) & (US$ Million) Table 43. Middle East & Africa Artificial Intelligence Drug R&D Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029 Table 44. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2018-2023) & (US$ Million) Table 45. Middle East & Africa Artificial Intelligence Drug R&D Market Size by Country (2024-2029) & (US$ Million) Table 46. IBM Watson Company Detail Table 47. IBM Watson Business Overview Table 48. IBM Watson Artificial Intelligence Drug R&D Product Table 49. IBM Watson Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million) Table 50. IBM Watson Recent Development Table 51. BioXel Company Detail Table 52. BioXel Business Overview Table 53. BioXel Artificial Intelligence Drug R&D Product Table 54. BioXel Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million) Table 55. BioXel Recent Development Table 56. Insilico Medicine Company Detail Table 57. Insilico Medicine Business Overview Table 58. Insilico Medicine Artificial Intelligence Drug R&D Product Table 59. Insilico Medicine Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million) Table 60. Insilico Medicine Recent Development Table 61. Gatehouse Bio Company Detail Table 62. Gatehouse Bio Business Overview Table 63. Gatehouse Bio Artificial Intelligence Drug R&D Product Table 64. Gatehouse Bio Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million) Table 65. Gatehouse Bio Recent Development Table 66. Google DeepMind Company Detail Table 67. Google DeepMind Business Overview Table 68. Google DeepMind Artificial Intelligence Drug R&D Product Table 69. Google DeepMind Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million) Table 70. Google DeepMind Recent Development Table 71. Genpact Cora Company Detail Table 72. Genpact Cora Business Overview Table 73. Genpact Cora Artificial Intelligence Drug R&D Product Table 74. Genpact Cora Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million) Table 75. Genpact Cora Recent Development Table 76. Cyclica Inc Company Detail Table 77. Cyclica Inc Business Overview Table 78. Cyclica Inc Artificial Intelligence Drug R&D Product Table 79. Cyclica Inc Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million) Table 80. Cyclica Inc Recent Development Table 81. QuantumBlack Company Detail Table 82. QuantumBlack Business Overview Table 83. QuantumBlack Artificial Intelligence Drug R&D Product Table 84. QuantumBlack Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million) Table 85. QuantumBlack Recent Development Table 86. Nq Medical Company Detail Table 87. Nq Medical Business Overview Table 88. Nq Medical Artificial Intelligence Drug R&D Product Table 89. Nq Medical Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million) Table 90. Nq Medical Recent Development Table 91. Phenomic AI Company Detail Table 92. Phenomic AI Business Overview Table 93. Phenomic AI Artificial Intelligence Drug R&D Product Table 94. Phenomic AI Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million) Table 95. Phenomic AI Recent Development Table 96. Palantir Technologies Company Detail Table 97. Palantir Technologies Business Overview Table 98. Palantir Technologies Artificial Intelligence Drug R&D Product Table 99. Palantir Technologies Revenue in Artificial Intelligence Drug R&D Business (2018-2023) & (US$ Million) Table 100. Palantir Technologies Recent Development Table 101. Research Programs/Design for This Report Table 102. Key Data Information from Secondary Sources Table 103. Key Data Information from Primary Sources List of Figures Figure 1. Global Artificial Intelligence Drug R&D Market Size Comparison by Type (2023-2029) & (US$ Million) Figure 2. Global Artificial Intelligence Drug R&D Market Share by Type: 2022 VS 2029 Figure 3. AI Platfrom Features Figure 4. Analytics Service Features Figure 5. Global Artificial Intelligence Drug R&D Market Size Comparison by Application (2023-2029) & (US$ Million) Figure 6. Global Artificial Intelligence Drug R&D Market Share by Application: 2022 VS 2029 Figure 7. Drug Discovery Case Studies Figure 8. Precision Medicine Case Studies Figure 9. Artificial Intelligence Drug R&D Report Years Considered Figure 10. Global Artificial Intelligence Drug R&D Market Size (US$ Million), Year-over-Year: 2018-2029 Figure 11. Global Artificial Intelligence Drug R&D Market Size, (US$ Million), 2018 VS 2022 VS 2029 Figure 12. Global Artificial Intelligence Drug R&D Market Share by Region: 2022 VS 2029 Figure 13. Global Artificial Intelligence Drug R&D Market Share by Players in 2022 Figure 14. Global Top Artificial Intelligence Drug R&D Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Artificial Intelligence Drug R&D as of 2022) Figure 15. The Top 10 and 5 Players Market Share by Artificial Intelligence Drug R&D Revenue in 2022 Figure 16. North America Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 17. North America Artificial Intelligence Drug R&D Market Share by Country (2018-2029) Figure 18. United States Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 19. Canada Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 20. Europe Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 21. Europe Artificial Intelligence Drug R&D Market Share by Country (2018-2029) Figure 22. Germany Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 23. France Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 24. U.K. Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 25. Italy Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 26. Russia Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 27. Nordic Countries Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 28. Asia-Pacific Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 29. Asia-Pacific Artificial Intelligence Drug R&D Market Share by Region (2018-2029) Figure 30. China Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 31. Japan Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 32. South Korea Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 33. Southeast Asia Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 34. India Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 35. Australia Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 36. Latin America Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 37. Latin America Artificial Intelligence Drug R&D Market Share by Country (2018-2029) Figure 38. Mexico Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 39. Brazil Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 40. Middle East & Africa Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 41. Middle East & Africa Artificial Intelligence Drug R&D Market Share by Country (2018-2029) Figure 42. Turkey Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 43. Saudi Arabia Artificial Intelligence Drug R&D Market Size YoY Growth (2018-2029) & (US$ Million) Figure 44. IBM Watson Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023) Figure 45. BioXel Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023) Figure 46. Insilico Medicine Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023) Figure 47. Gatehouse Bio Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023) Figure 48. Google DeepMind Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023) Figure 49. Genpact Cora Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023) Figure 50. Cyclica Inc Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023) Figure 51. QuantumBlack Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023) Figure 52. Nq Medical Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023) Figure 53. Phenomic AI Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023) Figure 54. Palantir Technologies Revenue Growth Rate in Artificial Intelligence Drug R&D Business (2018-2023) Figure 55. Bottom-up and Top-down Approaches for This Report Figure 56. Data Triangulation Figure 57. Key Executives Interviewed

IBM Watson BioXel Insilico Medicine Gatehouse Bio Google DeepMind Genpact Cora Cyclica Inc QuantumBlack Nq Medical Phenomic AI Palantir Technologies